Study helps explain wide response to statins
CHICAGO (Reuters) - Differences in the way people process genetic information may explain why some get a huge benefit from cholesterol-fighting drugs known as statins, while others get very little, U.S. researchers said on Monday.
<p><img src="http://feeds.reuters.com/~a/reuters/healthNews?i=ocKkpM" border="0"></img> (http://feeds.reuters.com/~a/reuters/healthNews?a=ocKkpM)</p><div class="feedflare">
<img src="http://feeds.reuters.com/~f/reuters/healthNews?i=ywPOuI" border="0"></img> (http://feeds.reuters.com/~f/reuters/healthNews?a=ywPOuI) <img src="http://feeds.reuters.com/~f/reuters/healthNews?i=OwuQgi" border="0"></img> (http://feeds.reuters.com/~f/reuters/healthNews?a=OwuQgi) <img src="http://feeds.reuters.com/~f/reuters/healthNews?i=sMA39i" border="0"></img> (http://feeds.reuters.com/~f/reuters/healthNews?a=sMA39i)
</div><img src="http://feeds.reuters.com/~r/reuters/healthNews/~4/313360776" height="1" width="1"/>
http://feeds.reuters.com/~r/reuters/healthNews/~3/313360776/idUSN1627790420080616